About Nortis
Nortis is a company based in Woodinville (United States) founded in 2007 was acquired by Quris in October 2024. Nortis has raised $10.66 million across 21 funding rounds from investors including HHS and Quris Ai. The company has 19 employees as of December 31, 2021. Nortis operates in a competitive market with competitors including Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
- Headquarter Woodinville, United States
- Employees 19 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Nortis Inc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Nortis
Unlock access to complete
Unlock access to complete
Funding Insights of Nortis
Nortis has successfully raised a total of $10.66M across 21 strategic funding rounds. The most recent funding activity was a Grant round of $275.45 thousand completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Nortis
Nortis has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Quris Ai.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked | |
|
AI-based drug candidate predicting tool for healthcare professionals
|
Locked | Locked | Locked |
Investor details for Nortis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Nortis
Investment portfolio details for Nortis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Nortis
Detailed financials for Nortis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Nortis Comparisons
Peer comparison for Nortis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Nortis
Nortis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emulate, CN Bio, AxoSim, Mimetas and Obatala Sciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of in vitro models for drug development
|
|
| Locked | Locked | Locked |
Organ-on-a-chip platforms are developed for drug discovery applications.
|
|
| Locked | Locked | Locked |
Nerve-on-a-chip technology is advanced by AxoSim for drug development improvement.
|
|
| Locked | Locked | Locked |
Microfluidics-based organ-on-a-chip models for drug evaluation are developed.
|
|
| Locked | Locked | Locked |
Provider of research enabling products and services to research centers
|
Detailed competitors of Nortis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Nortis
Complete news archive for Nortis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nortis
Nortis was founded in 2007.
Nortis is headquartered in Woodinville, United States. It is registered at Woodinville, Washington, United States.
Nortis is a funded company, having raised a total of $10.66M across 21 funding rounds to date.
As of Dec 31, 2021, the latest employee count at Nortis is 19.
Nortis was founded in 2007 in Woodinville, United States, within the biotechnology sector. A platform is developed for creating small segments of human tissues and organs using microfluidic chips. The ParVivoTM system is offered as a pre-seeded chip platform, enabling microphysiological environments for in vitro biomedical research and drug discovery applications. Operations focus on supporting research and development in these areas.